Table 3.

Serious adverse events.

	Mifepristone and misoprostol (N = 172)	Placebo and misoprostol (N = 172)	p-value
All Serious Adverse Events	24	55	0.000487
Hospital admissions	23 (13.4%)	53 (30.8%)	0.000579
Planned	17 (9.9%)	44 (25.6%)
-uterine aspiration	16	43
-clinical hysteroscopy	1	1
Unplanned	6 (3.5%)	9 (5.2%)
-uterine aspiration	3	8
-observation blood loss	3	1
No of other serious adverse events	1(0.6%)	2(1.2%)	0.500
Suspected pelvic infection requiring antibiotics	1 (0.6%)	1 (0.6%)
Heavy blood loss requiring blood transfusion	0	1 (0.6%)